Is PNC-27 FDA approved?
No. This profile records PNC-27 as not FDA approved and for research use only.
MORE CONTEXT ›
Review the regulatory and source details on this page for the current context.
Healing CATEGORY
PNC-27
THE CANCER TERMINATOR
HDM-2 Binding Peptide
PNC-27 is a synthetic peptide designed to selectively kill cancer cells while leaving healthy cells unharmed. It works by binding to HDM-2, a protein that cancer cells overexpress on their surface, and then forming pores in their membranes. This liberates the p53 tumor suppressor, allowing it to trigger cancer cell death. It's being researched for various cancers.
PNC-27
PNC-27
PNC-27
PNC-27 Evidence Snapshot
How these guides are reviewed
REGULATORY STATUS
Not FDA approved · research use only
DOSING GUIDANCE
Reviewed by our clinical team
LINKED EVIDENCE
1 research sources
CONTENT UPDATED
Aug 28, 2026
Dose and schedule recommendations shown below come from The Peptide App Clinical Team. Research links are provided so readers can inspect the supporting evidence directly. Review the sources.
Quick Answers About PNC-27
What dose does The Peptide App Clinical Team recommend for PNC-27?
Dose: 250 mcg daily (research protocol).
MORE CONTEXT ›
Schedule: daily. Cycle: 6 weeks on, 8 weeks off. This is clinical-team guidance for reference and does not replace individualized instructions from a licensed clinician.
What research supports this PNC-27 guide?
This guide links to 1 curated or current research sources.
MORE CONTEXT ›
Open the research section to inspect the source titles, publication details, study types, and available abstracts directly.
Studied Effects & Mechanisms
HDM-2 Binding
Binds to HDM-2 protein overexpressed on cancer cells
p53 Liberation
Frees p53 tumor suppressor to activate apoptosis
Membrane Pores
Forms channels in cancer cell membranes causing necrosis
Selectivity
Spares healthy cells lacking HDM-2 overexpression
Those exploring adjunctive cancer therapies
Those with cancers overexpressing HDM-2
Anyone researching selective anti-cancer peptides
PNC-27 Research
Live research temporarily unavailableThe live research feed did not return papers for this page. The curated references below remain available for crawlable source context.
RESEARCH REFERENCES